Novo Probe By U.S. Expands To Insulin Manufacturing
This article was originally published in The Pink Sheet Daily
Executive Summary
Massachusetts U.S. Attorney’s office, which is also investigating firm’s marketing, now subpoenas Novo Nordisk for documents relating to potential issues at its plant in Kalundborg, Denmark.
You may also be interested in...
Emerging Markets Earnings: Novo Nordisk Sticks To The Plan
Novo Nordisk has a plan in emerging markets and is sticking to it, as senior executives detailed in the third quarter earnings call.
Kickback Suit Against Novartis Can Proceed, Judge Says
Federal judge rules against Novartis’ motion to dismiss a whistleblower suit alleging violations of the anti-kickback statute and the False Claims Act, saying the government’s evidence is specific enough to proceed.
Under DOJ’s Microscope: Teva Is Latest Company To Face Government Probe
AstraZeneca, Merck, Novartis and Sanofi are also under investigation for potential health care fraud.